Allopurinol and endothelial function: A systematic review with meta-analysis of randomized controlled trials

被引:50
作者
Alem, Manal M. [1 ]
机构
[1] Alfaisal Univ, Coll Med, Dept Pharmacol, Riyadh, Saudi Arabia
关键词
allopurinol; endothelial dysfunction; oxidative stress; xanthine oxidase; xanthine oxidase inhibitor; CHRONIC HEART-FAILURE; XANTHINE-OXIDASE INHIBITION; VASCULAR OXIDATIVE STRESS; LEFT-VENTRICULAR MASS; SERUM URIC-ACID; KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; DYSFUNCTION; RISK; ATHEROSCLEROSIS;
D O I
10.1111/1755-5922.12432
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
AimOxidative stress and endothelial dysfunction are two inter-related conditions commonly seen in patients with cardiovascular risk factors. The enzyme, xanthine oxidase, is an important contributor to these phenomena but to a variable degree in different patient populations. This meta-analysis will summarize the effect of allopurinol, an established xanthine oxidase inhibitor, on endothelial function among patients with different comorbidities. MethodsMedline Complete, PubMed, ProQuest, ClinicalKey, Wiley Online Library, and Cochrane Central Register of Controlled Trials were searched till July 29, 2017. Meta-analysis was planned for randomized controlled trials (RCTs) that investigated allopurinol effects on endothelial function. A random effect model was used to calculate the standardized mean difference (with 95% confidence intervals: CI) as an estimate of effect size. Heterogeneity was quantified by four types of information: Q statistics, I-2 statistic, Tau-squared (T-2), and Tau (T). ResultsThirty eligible studies were identified; 12 were included in the final analysis and subdivided among 3 patient's groups: patients with chronic heart failure (CHF; 197 patients), patients with chronic kidney disease (CKD; 183 patients), and patients with type 2 diabetes mellitus (DM; 170 patients). Allopurinol was found to have a statistically significant benefit on endothelial function in patients with CHF and CKD but not in type 2 DM. The standardized mean differences and CI in the three patient's groups were 0.776 (0.429, 1.122), 0.350 (0.009, 0.690), and 1.331 (-0.781, 3.444), respectively. ConclusionAllopurinol has an antioxidant property that might partially reverse endothelial dysfunction in patients with certain comorbidities. The importance of this property and the magnitude of the beneficial effect are likely to be related to the relative contribution of xanthine oxidase into the oxidative stress associated with different underlying pathologies.
引用
收藏
页数:9
相关论文
共 55 条
[1]
Nitric oxide deficiency in chronic kidney disease [J].
Baylis, Chris .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (01) :F1-F9
[2]
The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients [J].
Bayram, Dilara ;
Sezer, M. Tugrul ;
Inal, Salih ;
Altuntas, Atila ;
Kidir, Veysel ;
Orhan, Hikmet .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (03) :443-449
[3]
Borenstein M., 2009, Introduction to Meta-Analysis, P21, DOI [10.1002/9780470743386.ch4, DOI 10.1002/9780470743386.CH4]
[4]
Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[5]
NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[6]
Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis [J].
Choi, Ji-Young ;
Yoon, Yoo Jeong ;
Choi, Hee-Jeong ;
Park, Sun-Hee ;
Kim, Chan-Duck ;
Kim, In-San ;
Kwon, Tae-Hwan ;
Do, Jun-Young ;
Kim, Sung-Ho ;
Ryu, Do Hyun ;
Hwang, Geum-Sook ;
Kim, Yong-Lim .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (04) :1304-1313
[7]
Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis [J].
Davey, Jonathan ;
Turner, Rebecca M. ;
Clarke, Mike J. ;
Higgins, Julian P. T. .
BMC MEDICAL RESEARCH METHODOLOGY, 2011, 11
[8]
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies [J].
Doehner, W ;
Schoene, N ;
Rauchhaus, M ;
Leyva-Leon, F ;
Pavitt, DV ;
Reaveley, DA ;
Schuler, G ;
Coats, AJS ;
Anker, SD ;
Hambrecht, R .
CIRCULATION, 2002, 105 (22) :2619-2624
[9]
Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients [J].
Dogan, Ali ;
Yarlioglues, Mikail ;
Kaya, Mehmet Gungor ;
Karadag, Zakir ;
Dogan, Serap ;
Ardic, Idris ;
Dogdu, Orhan ;
Kilinc, Yusuf ;
Zencir, Cemil ;
Akpek, Mahmut ;
Ozdogru, Ibrahim ;
Oguzhan, Abdurrahman ;
Kalay, Nihat .
BLOOD PRESSURE, 2011, 20 (03) :182-187
[10]
Oxidative stress is progressively enhanced with advancing stages of CKD [J].
Dounousi, Evangelia ;
Papavasiliou, Eleni ;
Makedou, Areti ;
Loannou, Kyriakos ;
Katopodis, Konstantinos P. ;
Tselepis, Alexandros ;
Siamopoulos, Kostas C. ;
Tsakiris, Dimitrios .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 48 (05) :752-760